Knockdown of EEF2K in melanoma cells reduced the levels of cholesterol and the protein levels of LDL-R (crucial for cholesterol uptake), HMGCR (rate limiting enzyme for cholesterol synthesis), and SREBP2 (transcriptional regulator of both pathways). Here, LDLR is linked to melanoma.